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Human colonic epithelia were cultured on a microfabricated
scaffold under a growth factor gradient to generate crypt
structures. Responses to cytokines or bacterial metabolite
gradients were assessed from altered stem and differentiated
cell numbers and locations.
BACKGROUND & AIMS: The successful culture of intestinal
organoids has greatly enhanced our understanding of intestinal
stem cell physiology and enabled the generation of novel in-
testinal disease models. Although of tremendous value, intes-
tinal organoid culture systems have not yet fully recapitulated
the anatomy or physiology of the in vivo intestinal epithelium.
The aim of this work was to re-create an intestinal epithelium
with a high density of polarized crypts that respond in a
physiologic manner to addition of growth factors, metabolites,
or cytokines to the basal or luminal tissue surface as occurs
in vivo.
METHODS: A self-renewing monolayer of human intestinal
epithelium was cultured on a collagen scaffold micro-
fabricated with an array of crypt-like invaginations. Placement
of chemical factors in either the ﬂuid reservoir below orabove the cell-covered scaffolding created a gradient of that
chemical across the growing epithelial tissue possessing
the in vitro crypt structures. Crypt polarization (size of the
stem/proliferative and differentiated cell zones) was assessed
in response to gradients of growth factors, cytokines, and
bacterial metabolites.
RESULTS: Chemical gradients applied to the shaped human
epithelium re-created the stem/proliferative and differenti-
ated cell zones of the in vivo intestine. Short-chain fatty
acids applied as a gradient from the luminal side conﬁrmed
long-standing hypotheses that butyrate diminished stem/
progenitor cell proliferation and promoted differentiation
into absorptive colonocytes. A gradient of interferon-g and
tumor necrosis factor-a signiﬁcantly suppressed the stem/
progenitor cell proliferation, altering crypt formation.
CONCLUSIONS: The in vitro human colon crypt array
accurately mimicked the architecture, luminal accessibility,
tissue polarity, cell migration, and cellular responses of in vivo
intestinal crypts. (Cell Mol Gastroenterol Hepatol
2018;5:113–130; https://doi.org/10.1016/j.jcmgh.2017.10.007)Keywords: Intestinal Epithelial Cells; Intestine-On-A-Chip; Stem
Cell Niche; Polarized Crypt.
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new approaches to drug testing and biological study.1
Organ-on-chip devices strive to combine microengineered
environments with living cells to produce physiologic
systems. Devices are being developed to recapitulate the
structure and function of a variety of organs, including liver,
heart, and lung.2 The expectation is that these devices,
particularly when incorporating human cells, will create a
revolution in the study of human biology and drug devel-
opment.3,4 Among these systems, the large intestine espe-
cially represents an important organ for in vitro study of
intestinal physiology and the evaluation of the effects of
pharmaceutical agents and microbial metabolites. For
example, pharma and food companies are intensely
interested in screening the gut microbiome and the effects
of prebiotics and probiotics by virtue of their roles in
metabolism and their inﬂuences on the human body.5,6
Despite this importance, major challenges exist in creating
an in vitro intestinal epithelium because the intestinal lining
is a highly polarized tissue and primary gut epithelium
rapidly dies in standard culture. Current gold standard
methods for intestinal assays use tumor cell lines, such as
Caco-2, and animals.7–10 This is problematic because tumor
cells lack many of the features of normal intestinal tissue
and animal models are expensive and increasingly fraught
by ethical concerns.
Recently developed intestinal stem-cell culture methods
are expected to dramatically improve this situation.11,12 It
now is possible to create multicellular structures known as
organoids or mini-guts from primary animal and human stem
cells.13–15 These structures possess self-renewing stem cells
and their differentiated progeny to reproduce intestinal
epithelium in a culture dish. The potential for the organoid
technology is enormous; nevertheless, the enclosed cystic,
spherical architecture of organoids presents severe limi-
tations.16–20 Because of the bulk properties of the matrix and
lack of spatial control of growth factors (eg, biochemical gra-
dients), intestinal organoids formembeddedwithin a paddyof
Matrigel (Corning, Tewksbury, MA) with an enclosed, inac-
cessible lumen and random buds lacking distinct stem/
transit-amplifying and differentiated cell compartments.21,22
These characteristics preclude the use of the organoid sys-
tem in numerous applications and a true living construct
suitable for assay of dietary metabolites, cytokines, microor-
ganisms, and drug interactions has not been available.23,24
What is needed is the ability to recreate the epithelium of
the organoid system in an open-faced geometry while main-
taining its cellular composition, polarity, and physiology. Our
group has been striving to achieve such an intestine-on-chip
system for both small and large intestines.25–32
To address the limitation of the enclosed lumen of orga-
noids, we surveyed a variety of biomaterials, and identiﬁed a
collagen hydrogel scaffold that enabled a self-renewing planar
monolayer culture of colonic epithelial cells with properties
similar to those of organoids, but whose luminal surface wasreadily accessible.25 Nevertheless, these monolayers lacked
the 3-dimensional architecture and tissue polarity of in vivo
colon crypts. To overcome this shortcoming, in the current
study we incorporated microfabrication of the hydrogel scaf-
fold and spatial control of growth factors in a simple-to-use
open format. Primary cells from a colonoscopic biopsy were
ﬁrst expanded in the aforementioned monolayer system. The
collagen hydrogel scaffold was microfabricated in a microwell
architecture possessing the shape of human colonic crypts.
A gradient of growth factors along the crypts’ z-axis was
used to induce the polarization of the crypts such that stem/
progenitor cells were conﬁned to the basal region, while non-
proliferative cells were situated along the upper and luminal
aspects of the crypts. The in vitro human colonic crypts were
compared with native in vivo colon crypts in terms of archi-
tecture, luminal patency, tissue polarity, and cell migration. To
show the utility of this organ-on-a-chip system, the platform
was used to study the impact of metabolites and cytokines on
cellular proliferation and location within the tissue.Materials and Methods
Cell Culture Media
The media compositions are listed in Tables 1 and 2. The
culture media (expansion medium [EM], stem medium [SM],
and differentiation medium [DM]) for human colonic crypts
and epithelial cells were prepared from amixture of advanced
Dulbecco’s modiﬁed Eagle medium/F12 medium (12634010;
ThermoFisher, Waltham, MA) and Wnt-3A, R-spondin 3,
noggin (WRN) conditionedmedium (see later) at a volumetric
ratio of 1:1, and supplementedwith 1 GlutaMAX (35050061;
ThermoFisher), 1 B27 supplement (12587010; Thermo-
Fisher), 10 mmol/L HEPES (15630-080; ThermoFisher), 1.25
mmol/LN-acetyl cysteine (194603;MPBio, Santa Ana, CA), 10
mmol/L nicotinamide (N0636; Sigma-Aldrich, St. Louis, MO),
50 ng/mL epidermal growth factor (315-09; Peprotech, Rocky
Hill, NJ), 10 nmol/L gastrin (AS-64149; Anaspec, Fremont, CA),
10 nmol/L prostaglandin E2 (14010; Cayman Chemicals, Ann
Arbor, MI), 3 mmol/L SB202190 (S1077; Selleckchem, Hous-
ton, TX), 100 U/mL penicillin-streptomycin (15140122;
ThermoFisher), and50mg/mLprimocin (ant-pm-1; InvivoGen,
San Diego, CA).33 A total of 10 mmol/L Y27632 (A3008-200;
ApexBio, Houston, TX) was used in the ﬁrst 48 hours after cell
plating to prevent dissociation-induced cell apoptosis. WRN
Table 1.Supplier, Catalog Number, Stock Solution Concentration, and Storage Condition of Reagents
Reagent Suppliers Catalog number Stock solution Storage
WRN–conditioned medium Made in-house -20C
Advanced DMEM/F12 ThermoFisher 12634-010 4C
GlutaMax ThermoFisher 35050061 100 4C
HEPES ThermoFisher 15630-080 1 mol/L 4C
Gentamycin ThermoFisher 15750060 50 mg/mL 4C
Primocin InvivoGen ant-pm-1 50 mg/mL -20C
B27 ThermoFisher 12587010 50 -20C
N-acetyl cysteine MP Bio 194603 1 mol/L in PBS -20C
Murine EGF Peprotech 315-09 250 mg/mL in 0.1% BSA -20C
Nicotinamide Sigma N0636-100G 1 mol/L in PBS -20C
Gastrin Anaspec AS-64149 1 mg/mL in 0.1% BSA -20C
Prostaglandin E2 Cayman Chemicals 14010 1 mmol/L in DMSO -20C
A83-01 Sigma SML0788 5 mmol/L in DMSO -20C
SB202190 Selleckchem S1077 30 mmol/L in DMSO -20C
Y27632 ApexBio A3008-200 10 mmol/L in PBS -20C
Sodium butyrate Acros Organics 263190050 500 mmol/L in PBS -20C
DAPT Xcessbio M60023-5 10 mmol/L in DMSO -20C
TNF-a Peprotech 300-01A 10 mg/mL in 0.1% BSA -20C
IFN-g Peprotech 300-02 10 mg/mL in 0.1% BSA -20C
DMEM, Dulbecco’s modiﬁed Eagle medium; DMSO, dimethyl sulfoxide; EGF, epidermal growth factor.
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3276; ATCC, Manassas, VA) following a published protocol.14
This cell line produces Wnt-3A, R-spondin 3, and noggin. EM
was used to expand the epithelial cell numbers as monolayers
or organoids. A83-01 (SML0788; Sigma), a transforming
growth factor-b inhibitor, was not included in the EM. SM andTable 2.Formulation of Culture Media for Human Colonic
Epithelial Cells
Reagent EM SM DM
WRN–conditioned
medium
50 vol% 50 vol%
Advanced DMEM/F12 50 vol% 50 vol% 100 vol%
GlutaMax 1 1 1
HEPES 10 mmol/L 10 mmol/L 10 mmol/L
Primocin 50 mg/mL 50 mg/mL 50 mg/mL
N-acetyl cysteine 1.25 mmol/L 1.25 mmol/L 1.25 mmol/L





A83-01 500 nmol/L 500 nmol/L
SB202190 3 mmol/L
Y27632 10 mmol/La
DMEM, Dulbecco’s modiﬁed Eagle medium; EGF, epidermal
growth factor.
aUsed in the ﬁrst 48 hours after cell plating to prevent
dissociation-induced cell apoptosis.DM both contained A83-01 (500 ng/mL) because the cells
adopted amore columnarmorphology under these conditions.
Isolation of Crypts From Human Colonic
Biopsy Specimens
Biopsy specimens of human colonic epithelium were
obtained during routine screening colonoscopies performed
at University of North Carolina’s Hospital Meadowmont
Endoscopy Center with consent of the patient (under the
approved University of North Carolina Institutional Review
Board #14-2013). Crypts were isolated from the biopsy
specimens by incubation with EDTA (2 mmol/L) and
dithiothreitol (0.5 mmol/L) in an isolation buffer for 75
minutes at 20C followed by vigorous shaking in a 15-mL
conical tube. The isolation buffer was composed of 5.6
mmol/L Na2HPO4, 8.0 mmol/L KH2PO4, 96.2 mmol/L NaCl,
1.6 mmol/L KCl, 43.4 mmol/L sucrose, and 54.9 mmol/L
D-sorbitol, pH ¼ 7.4.13 Hundreds of crypts were released
from each biopsy, and the crypts were placed into either
monolayer or organoid culture within 30 minutes of isolation.
Organoid Culture With Matrigel Embedding
Released crypts were embedded in Matrigel for organoid
culture as described previously.13,14 Brieﬂy, 500 crypts were
suspended in 100 mL of cold Matrigel (356235; Corning,
Tewksbury,MA) and then 20mL of this suspensionwas added
to each well of a 24-well plate. After Matrigel gelation at 37C
for 15 minutes, 500 mL of EM was added to each well. The
medium was changed every 48 hours. Y27632 was added to
the medium only for the ﬁrst 48 hours. Every 5 to 7 days the
organoids were dissociated with Accutase (07920; Stemcell
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plate after dilution of the cells by one third.
Monolayer Culture on a Neutralized
Collagen Hydrogel
Human colonic epithelial cells were expanded as a
monolayer on a neutralized collagen hydrogel as described
previously.25 To prepare 36 mL of a neutralized collagen
solution (1mg/mL), 7.4 mL of collagen (356236; Corning; rat
tail, type I, 4.89 mg/mL in 20 mmol/L acetic acid) was mixed
with 170 mL of sodium hydroxide (stock concentration of 1 N,
working concentration of 23 mmol/L), 720 mL of HEPES
(15630080; ThermoFisher; stock concentration of 1 mol/L,
working concentration of 20 mmol/L), 2.16 mL of sodium
bicarbonate (25-035-CI; Corning; stock concentration of
7.5% wt/vol, working concentration of 0.45% wt/vol), 3.6
mL of 10 phosphate-buffered saline (PBS) (46-013-CM;
Corning; working concentration of 1), and 21.95 mL of
deionized water on ice. The mixture was added to 6-well
plates (T1006; Denville, Holliston, MA) at 1 mL per well.
The plates were incubated at 37C for 1 hour to generate a
clear hydrogel. Four milliliters of PBS was added to each well
to hydrate the hydrogel. The plates were placed in a sealed
plastic bag and stored at room temperature for up to 3
months. The hydrogel was incubated in PBS buffer for at least
15 days before cell culture. This incubation step was critical
for successful culture of the self-renewing epithelial cells and
may result in a change in stiffness and other hydrogel prop-
erties as the gel matured over the 15-day time span.
Before plating crypts or epithelial cells, the collagen
hydrogels were rinsed 3 times with 4 mL of PBS for 5 mi-
nutes to remove accumulated salt as a result of water
evaporation during storage. Isolated crypts were placed on
the top of the collagen hydrogel at a density of 500 crypts/
well of a 6-well plate and overlaid with EM (4 mL). The
medium was changed every 48 hours. When the cell
coverage was greater than 80% (typically 5–7 days), the
monolayers were passaged by a gentle 2-step dissociation
method.25 The ﬁrst step was to detach the monolayer from
the collagen hydrogel by breaking the hydrogel into pieces
by repeated pipetting followed by incubating the hydrogel
with 500 U/mL collagenase at 37C for 10 minutes. The
second step was to further split the cell fragments into
smaller pieces by incubating the mixture with 150 mL of
EDTA (0.5 mmol/L) and Y27632 (10 mmol/L) in PBS at 37C
for 5 minutes. The monolayers again were dispersed by
pipetting up and down 30 times using a 200-mL pipet tip.
The cell fragments were resuspended in medium and sub-
cultured on a new collagen hydrogel at a passage ratio of
1:3. To ensure that the cells possessed normal chromo-
somes, cells were karyotyped (KaryoLogic, Inc, Research
Triangle Park, NC) at passage (P)7 and P11. Twenty cells
from each sample were analyzed. All experiments used the
cells between P5 and P10.
Lineage Differentiation
Lineage differentiation was performed using a protocol
adapted from that published previously.34 Cells werecultured as monolayers in EM for 4 days followed by culture
in DM for 4 days to initiate cell differentiation. Both EM and
DM were changed every 48 hours. DM did not contain
growth factors (Wnt-3A, R-spondin, or noggin). Sodium
butyrate (B; 5 mmol/L, 263190050; Acros Organics, Wal-
tham, MA), g-secretase inhibitor DAPT (N-[(3,5-Diﬂuor-
ophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethyl
ester; 10 mmol/L, M60023-5; Xcessbio, San Diego, CA) were
added as indicated to induce differentiation into either
absorptive colonocytes or mucus-producing goblet cells.Microfabrication and Surface Modiﬁcation of
Polydimethylsiloxane Stamps
Polydimethylsiloxane (PDMS) stamps were used to
micromold collagen scaffolds with an array of microwells.
The PDMS stamps possessed an array of microposts with
slanted walls and rounded top surfaces (height, 430 mm;
base diameter, 125 mm). A custom-formulated 1002F epoxy
photoresist was used to generate high-aspect ratio micro-
posts. Formulation of 1002F photoresist was described in a
previous publication.35 A ﬁlm of 1002F photoresist of 150-
mm thickness was created on a glass slide by spin-coating
1002F photoresist (formulation 100) on a glass slide (75
mm  50 mm  1 mm; Corning). After baking at 95C for 60
minutes, a second layer of 1002F of 150-mm thickness was
spin-coated on the top of the ﬁrst layer. After baking at 95C
for 60 minutes, a third layer of 1002F of 130-mm thickness
was spin-coated on the top of the second layer. The ﬁlm
(total thickness, 430 mm) was baked at 95C for 60 minutes
to evaporate the solvent. To create the sloped post sidewall,
the ﬁlm was exposed to UV light at a dose of 1500 mJ/cm2
from the backside (ie, through the glass slide). A post-
exposure baking was next performed in a 95C oven for 10
minutes followed by baking on a 120C hotplate for 10
minutes. The resist then was developed with propylene
glycol monomethyl ether acetate for 60 minutes, and baked
on a 120C hotplate for 60 minutes to harden the ﬁlm. PDMS
stamp 1 was created from the earlier 1002F master mold by
spreading PDMS prepolymer on the mold followed by
degassing under a vacuum. PDMS on the mold was baked in
a 95C oven for 30 minutes followed by demolding. The
demolded PDMS possessed an array of microwells. The
PDMS mold was treated with plasma for 2 minutes, and
coated with octyltrichlorosilane using a vapor-phase pro-
cess for 16 hours. A second PDMS stamp (stamp 2) was
replicated in the same manner from stamp 1 to create a
negative replica with an array of posts with slanted sides.
The PDMS stamps were coated with poly(ethylene gly-
col) to eliminate collagen adhesion during micromolding.
The PDMS stamps were surface-grafted with poly(ethylene
glycol) as described previously using UV-mediated graft
polymerization.36 Brieﬂy, PDMS stamps were placed in a
glass tube with a screw-cap (GL 25, polytetraﬂuoroethylene
[PTFE] protected seal; Schott, Elmsford, NY). The tube was
ﬁlled with a mixture of 10 wt% poly(ethylene glycol) methyl
ether acrylate monomer (454990; Sigma-Aldrich, St. Louis,
MO), 0.5 mmol/L sodium periodate (311448; Sigma-
Aldrich), 0.5 wt% benzyl alcohol (108006; Sigma-Aldrich)
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Loctite 7411-S UV Flood System (Henkel, Düsseldorf, Ger-
many) for 4 hours. The stamps then were rinsed with
deionized water and incubated in deionized water overnight
to remove noncovalently attached polymer and monomer.
The grafted stamps were stored in 75% ethanol until use.
Micromolding Collagen Scaffolds on a Modiﬁed
Transwell Insert
A cross-linked collagen scaffold possessing microwell
structures was micromolded on the top of a porous mem-
brane in a modiﬁed 12-well Transwell insert (3401; Corn-
ing, Tewksbury, MA) using a PDMS stamp. To construct the
modiﬁed insert, the polycarbonate porous membrane was
removed from the Transwell insert using sandpaper. Next, a
hydrophilic PTFE porous membrane (BGCM00010; Milli-
pore, Burlington, MA) was attached to the insert using a
biocompatible transfer adhesive (1504XL; 3M, Moncure,
NC). To reduce the effective area of the porous membrane
(ie, from 12-mm diameter to 3-mm diameter), the backside
of the porous membrane was blocked by attaching a non-
permeable cyclic oleﬁn copolymer plastic ﬁlm (4-mL thick,
TOPAS 6013; TOPAS Advanced Polymers, Florence, KY).
Collagen in the absence of acetic acid was used for
micromolding because the acetic acid (low pH) interfered
with the cross-linking reaction. Acetic acid was removed by
freeze drying the collagen solution (20 mmol/L acetic acid)
on a lyophilizer for 72 hours, followed by redissolving the
dried collagen solid in 2-(N-morpholino)ethanesulfonic acid
buffer (0.1 mol/L, pH 5) to generate a 5 mg/mL collagen
solution. Collagen solution (400 mL), 600 mmol/L 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC;
50 mL), and 150 mmol/L N-hydroxysuccinimide (NHS; 50
mL) were mixed in a conical tube on ice by pipetting up and
down 40 times. The trapped air bubbles in the mixture were
removed by centrifugation at 3000g for 1 minute. The
modiﬁed Transwell inserts were placed in a 12-well plate.
Collagen mixture (50 mL) was added to the center of the
Transwell insert, and a PDMS stamp was placed on the top
of the mixture. (Note that the mixture starts to gel within 5
minutes upon mixing the collagen with EDC and NHS. Thus,
the earlier-described steps must be completed within 5
minutes.) To remove the trapped air bubbles among the
microposts of the PDMS stamp, the 12-well plate was placed
inside a pressure pot (448PP; Dental Planet, Wichita Falls,
TX), and pressurized to 40 psi using nitrogen for 2 hours.
After removal of the plate from the pot, the insert was
incubated in deionized water, and the PDMS stamp was
demolded from the solidiﬁed collagen scaffold. The collagen
scaffold was incubated in 2 L of deionized water for 24
hours to remove residual EDC/NHS. The scaffolds were
sterilized with 75% ethanol for 5 minutes, rinsed with PBS
for 5 minutes 3 times, and stored in PBS at 4C until use.
Characterization of Chemical Gradients Applied
Across the Scaffold
An impermeable plastic ﬁlm was attached to the porous
membrane on the side opposite to the scaffold to reduce theavailable area for transport across the membrane from 113
mm2 (standard 12-well Transwell size) to 7 mm2. The ﬁlm
decreased the area available for diffusion so that upper and
lower reservoirs could be approximated as an inﬁnite
source and sink. To characterize the chemical gradient
proﬁle over time, 100 mg/mL of ﬂuorescein-dextran (mo-
lecular weight, 40 kilodaltons) was added either to the top
compartment (0.5 mL) or to the bottom compartment (1.5
mL). PBS then was added to the other compartment (bottom
compartment, 1.5 mL; top compartment, 0.5 mL). The
ﬂuorescein-dextran concentration was measured at 24, 48,
and 72 hours in the compartment originally ﬁlled with PBS.
Generating In Vitro Crypts
In vitro crypts were formed by culturing cells on the
micromolded scaffolds followed by application of a chemical
gradient across the scaffold. Before plating cells on the
micromolded collagen scaffold, the scaffold was coated with
10 mg/mL human collagen (5007-20ML; Advanced Biomatrix,
San Diego, CA) in PBS at 37C overnight. The scaffold was
rinsed with 2 mL PBS. Monolayers of primary cells were
expanded on the neutralized collagen hydrogel in a 6-well
plate as described earlier in the “Monolayer Culture on a
Neutralized Collagen Hydrogel” section.When themonolayers
reached>80% conﬂuency, the monolayer was detached from
the collagen by incubation with collagenase and then frag-
mented by EDTA and mechanical agitation as described
earlier. The cells then were plated on the top surface of the
micromolded collagen in the modiﬁed Transwell insert. Cells
from 1 well of the 6-well plate were dispersed into 4 separate
modiﬁed 12-well Transwell inserts. The cells were cultured in
3 mL EM per well (1 mL in the top compartment, and 2 mL in
the bottom compartment), and the medium was exchanged
every 48 hours. When the cells covered the entire surface of
the scaffolds, typically approximately 7 days, a gradient of
growth factorswas applied across the shaped collagen scaffold
and cells. DM (0.5 mL) was placed into the top compartment,
and SM (1.5mL)was added into the bottomcompartment. The
DM and SM were changed daily to maintain a stable gradient
across the collagen scaffold or long axis of the in vitro crypt.
Typically, polarization of the in vitro tissue was observed in 4
days under these chemical gradient conditions. When main-
tained under this chemical gradient, the polarized tissue was
maintained for up to 32 days (the longest time tested). To
assay the impact of other chemical gradients on crypt polarity,
short-chain fatty acids (SCFAs) or cytokines (100 ng/mL
tumor necrosis factor-a (TNF-a) [300-01A; Peprotech] and 10
ng/mL interferon-g (IFN-g) [300-02; Peprotech]) were added
to either the top or bottom compartment as indicated.
Simultaneous Assay of 5-Ethynyl-2-Deoxyuridine
Incorporation, Alkaline Phosphatase Activity,
Mucin 2 Presence, and DNA Content
Living cells were pulsed with 5-ethynyl-2-deoxyuridine
(EdU) and assayed for alkaline phosphatase (ALP). The cells
thenwereﬁxed and sequentially stained for EdU incorporation
(S-phase cells), mucin 2, and DNA. Cells were ﬁrst pulsed with
10 mmol/L of EdU for 24 hours at 37C, rinsed with PBS, and
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ratories, Burlingame, CA) inTris buffer (0.15mol/L, pH8.4) for
30minutes at 37C. The cellswere rinsedwithPBS,ﬁxed in4%
paraformaldehyde for 15 minutes, and permeabilized with
0.5% Triton X-100 in PBS for 20 minutes. Incorporated EdU
was labeled with Click-iT EdU Alexa Fluor 647 (C10340;
ThermoFisher). The cells were then rinsedwith 0.75% glycine
in PBS for 5 minutes 3 times, followed by blocking with 10%
donkey serum (017-000-121; Jackson Immunoresearch, West
Grove, PA) for 1 hour. The cells were incubated in rabbitmucin
2 (Muc2) antibody (1:200, sc-15334; Santa Cruz Biotech-
nology, Dallas, TX) at 4C overnight, and stained with donkey
anti-rabbit IgG-conjugated Alexa Fluor 488 (1:500, 711-545-
152; Jackson Immunoresearch) for 45 minutes. Finally, the
DNA was stained with Hoechst 33342 (2 mg/mL, B2261;
Sigma-Aldrich) for 15 minutes.Quantiﬁcation of Mucin Secretion and
ALP Activity
The protein level of Muc2 secreted by the cells into the
supernatant was determined quantitatively by a direct
enzyme-linked immunosorbent array (ELISA) adapted from
a previous publication.37 Cells were incubated for 48 hours
and their supernatant collected and diluted with coating
buffer (0.1 mol/L sodium carbonate, pH 9.5) at a ratio be-
tween 1:10 and 1:100, and 100 mL was added to each well
of an ELISA plate (15042; ThermoFisher). The plate was
incubated in a 40C oven overnight to let the samples dry.
The wells then were washed 3 times with 200 mL PBS,
blocked with 200 mL of 1% bovine serum albumin (BSA)
(A9647; Sigma) in PBS for 1 hour at room temperature, and
incubated with 100 mL of horseradish peroxidase (HRP)-
conjugated MUC2 primary antibody (sc-515032; Santa Cruz
Biotechnology; diluted in 1% BSA to 15 ng/mL) for 16 hours
at 4C. The wells then were washed 5 times with 200 mL of
0.05% Tween-20 in PBS. SuperSignal ELISA Femto horse-
radish peroxidase substrate (37075; ThermoFisher; 10
dilution in deionized water, 100 mL) was added to each well.
After 10 minutes, the luminescence was measured using a
plate reader (SpectraMax M5; Molecular Devices, Sunnyvale,
CA). Media from wells without cells were used as a control.
The results are expressed as a percentage of the control
medium and were normalized to the total protein content of
the cells from which the supernatant was collected.
To measure the ALP enzymatic activity, the cells were
detached from the collagen hydrogel by incubation in
collagenase for 15 minutes at 37C as described in a pre-
vious section, and washed twice with 5 mL PBS. The cell
pellets were lysed with 200 mL lysis buffer (1% Triton
X-100, 150 mmol/L KCl, 50 mmol/L HEPES, 5 mmol/L
EDTA, 5% glycerol), vortexed, and incubated on ice for 20
minutes. After centrifugation at 10,000g (10 min, 4C), the
supernatants were collected to quantify ALP activity and the
total protein content. The ALP activity of the cell lysates
was measured using the Sensolyte luminescent ALP assay
(AS-72122; Anaspec, Fremont, CA). ALP from calf intestine
was used as a positive control and standard. The protein
concentration of the cell lysates was measured by a Pierce isnow a ThermoFisher trademark, not a company. There is no
need to provide address for Pierce BCA protein assay
(23225; ThermoFisher). The ALP activity is expressed as
picograms equivalent to the calf intestine standard and
normalized to the cell protein amount. Three wells were
used for the measurements of both mucin secretion and ALP
activity (n ¼ 3).
Immunoﬂuorescence Staining
Immunoﬂuorescence was used to show the presence of
different cell types and subcellular structures of a tissue (eg,
biopsies, monolayers, organoids, in vitro crypts). To obtain
tissue slices, the specimen was ﬁrst ﬁxed in 4% para-
formaldehyde for 15minutes, rinsedwith PBS, and incubated
in 30% sucrose at 4C overnight. The tissue then was
embedded in a cryo-embedding optimal cutting temperature
(OCT) medium (Tissue-Tek O.C.T. Compound, VWR, Radnor,
PA), and the frozen tissue block was sectioned into 10-
mm–thick ﬁlms by a cryostat. For zonula occludens-1 (ZO-1),
E-cadherin, occludin, and b-catenin, the cells were ﬁxed with
ice-cold methanol and placed at -20C for 15 minutes. To
preserve mucins for Muc2 staining on in vitro crypts, the
tissue was ﬁxed with Carnoy’s solution (90% methanol and
10% acetic acid) for 30 minutes. For immunostaining, the
primary antibodies used were antibodies to olfactomedin-4
(Olfm4) (1:500, 14369; Cell Signaling Techology, Danvers,
MA), cytokeratin 20 (KRT20) (1:500, 60183-1-lg; Pro-
teinTech), Muc2 (1:200, sc-15334; Santa Cruz Biotech-
nology), ezrin (1:200, PA5-17518; ThermoFisher), integrin
b4 (1:200, sc-9090; Santa Cruz Biotechnology), ZO-1 (1:100,
21773-1-AP; Proteintech, Rosemont, IL), b-catenin (1:200,
sc-9090; Santa Cruz Biotechnology), occludin (1:100, 13409-
1-AP; Proteintech), and E-cadherin (1:100, 20874-1-AP;
Proteintech). Antigen retrieval was performed when speci-
mens were stained for Oﬂm4 and KRT20. For other stains,
antigen retrieval was not required to visualize immunoﬂuo-
rescence staining. For antigen retrieval, the specimen sec-
tions were rinsed with PBS 3 times to remove the cryo-
embedding OCTmedium. The slideswere placed in a retrieval
solution (RV1000MMRTU, Reveal Decloaker; Biocare Medi-
cal, Pacheco, CA) in a plastic Coplin jar in a 95Cwater bath for
15 minutes. The jar then was placed at 20C for 15 minutes.
The sections with and without antigen retrieval then were
rinsed with PBS and blocked with 10% donkey serum for 1
hour at 20C. The sections were incubated with primary an-
tibodies overnight at 4C. The sections thenwere stainedwith
secondary antibody, donkey anti-rabbit, or mouse IgG con-
jugated with Alexa Fluor 488 or 594 (1:500, 711-585-152 or
715-585-150; Jackson Immunoresearch). The nuclei were
stained with Hoechst 33342 (2 mg/mL) for 15 minutes.
Electron Microscopy
For scanning electron microscopy (SEM), samples were
dried with a critical point dryer (PVT-3, Tousimis Semidri,
Rockville, MD), coated with 10-nm metal by a sputter coater
(Cressington 108, Cresington Scientiﬁc Instruments,
Watford, UK), and inspected by a SEM (FEI Quanta 200
ESEM; FEI Company, Hillsboro, OR).
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Specimens were imaged using a Nikon Eclipse TE300
inverted epiﬂuorescence microscope (Nikon, Melville, NY)
equipped with 40,6-diamidino-2-phenylindole/ﬂuorescein
isothiocyanate/Texas Red/Cyanine 5 (CY5) ﬁlter sets. Im-
ages were acquired at randomly selected locations within a
specimen using a 10 (N.A. numerical aperture (N.A.) ¼ 0.3)
or 4 (N.A. ¼ 0.13) objective. S-phase cells stained with EdU
were imaged using a CY5 ﬁlter (excitation ﬁlter, 604–644
nm; emission, 672–712 nm), ALP stain was imaged with a
Texas Red ﬁlter (excitation ﬁlter, 542–582 nm; emission,
604–644 nm), Muc2 immunoﬂuorescence was visualized
with a ﬂuorescein ﬁlter (excitation ﬁlter, 450–490 nm;
emission, 520 nm long pass), and DNA stained by Hoechst
33342 was identiﬁed using a 40,6-diamidino-2-phenylindole
ﬁlter (excitation ﬁlter, 352–402 nm; emission, 417-477 nm).
Confocal microscopy was performed using a confocal
laser scanning microscope (Fluoview FV3000; Olympus,
Waltham, MA) with laser-based excitation and emission
wavelengths selected using a holographic transmission
diffraction grating.
Image Analysis
Images were empirically thresholded using ImageJ soft-
ware (https://imagej.nih.gov/ij/). ImageJ also was used to
quantitatively measure the monolayer surface area pos-
sessing suprathreshold ﬂuorescence for the EdU, ALP, or
Muc2 stains. The identiﬁed surface area then was divided by
the total cell area calculated from the image area positive for
Hoechst ﬂuorescence (DNA stain) and expressed as a per-
centage cell area positive for the EdU, ALP, or Muc2 stain.
All data used 5 randomly selected locations of the same
monolayer (n ¼ 5), and the average with a single SD is
shown unless otherwise speciﬁed.
Statistics
Statistical analysis was performed using a 1-way analysis
of variance followed by a multiple comparison test with the
Tukey honest signiﬁcant difference procedure conducted at
the 5% signiﬁcance level. All analyses of variance returned P
values less than .004. Multiple comparison testing was per-
formed on all pairwise comparisons between experimental
groups. Analyses of variance and subsequent multiple com-
parisons were performed using MATLAB (MATLAB 2014b;
The MathWorks, Inc, Natick, MA). An unpaired 2-tailed Stu-
dent t test was used to compare the outcomes from 2 exper-
imental conditions in the cytokine perturbation experiment.
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript.
Imaging and Assay of Whole Crypts Detached
From the In Vitro Tissue
Before removal from the tissue, the crypts were stained as
described earlier for EdU incorporation, ALP activity, Muc2
presence, or DNA content. To assess the polarity of the in vitro
crypts, a side view of the intact crypts was obtained by
scraping the crypts loose from the tissue and scaffold using a
tungsten dissecting needle (RS-6063; Roboz SurgicalInstrument Co, Gaithersburg, MD). Detached crypts were
overlaid onto a glass slide onto which they settled, lying in a
horizontal position. The crypts then were imaged using stan-
dard ﬂuorescence microscopy. The position of proliferating
cells (EdUþ) along the basal–luminal crypt axis was obtained
by evenly dividing the crypt into 8 regions. The ﬂuorescence
intensity ratio of the EdU stain relative to that of Hoechst
ﬂuorescence (DNA) from each region was obtained by ImageJ.
TheEdU/Hoechst ratio thenwas plotted against position along
the basal–luminal crypt axis. Twenty crypts were quantiﬁed
under identical ﬂuorescence measurement conditions.
To assay the impact of SCFAs or cytokines on the polarity
of in vitro crypts, the crypts were scraped from the array and
imaged as described earlier. The number of S-phase cells per
crypt was obtained by manually counting the number of
EdUþ cells per crypt using ImageJ. The relative proliferation
length (expressed as a percentage) is deﬁned as the length of
the crypt possessing EdUþ cells divided by the total length
of the crypt. The normalized ALP activity of the crypts was
obtained by measuring the total ﬂuorescence intensity of the
ALP stain divided by the ﬂuorescence intensity of the
Hoechst DNA stain. More than 10 crypts were quantiﬁed for
each data point under identical imaging conditions.
Unless otherwise speciﬁed, the data shown for a single
experiment used crypts or cells obtained from a single bi-
opsy (male; age, 52 y). Experiments used material from
biopsy specimens from 3 different human beings and the
results were consistent over time without outliers. Data
from representative experiments are presented.
Results
Organoid Culture of Human Colonic
Epithelial Cells
The luminal surface of the human colonic epithelium
possesses a high density of crypts or invaginations inter-
spersed among luminal columnar cells (Figure 1A). Between
these cell-covered invaginations lies a lamina propria that
shapes and supports the crypt and its cells. Proliferative
stem/progenitor cells (Olfm4þ) are conﬁned to the basal
side of the crypts, while the nondividing differentiated cells
are located at the luminal surface.38,39 This exquisite tissue
polarity with compartmentalization of proliferative and
differentiated cells is thought to be maintained in vivo by a
gradient of well-balanced growth signals (Wnt-3A, Notch,
bone morphogenic protein [BMP], and other factors) span-
ning the long axis of crypt from the luminal to the basal
region.40 This microenvironment also ensures the unidi-
rectional migration of cells from the proliferative to the
differentiated cell zone so that the luminal epithelial cells
are replaced every 5–7 days.41 The U shape of the crypt
permits the stem cells to be in a contiguous monolayer with
their differentiated progeny while surrounded by a chemical
microenvironment distinct from that of their differentiated
offspring. The growth-factor–rich microenvironment sup-
ports the stem cells as they proliferate and protects these
cells from the harsh milieu found within the colonic
lumen.42 Isolation of crypts from the colon and placement
within a Matrigel patty with appropriate supporting growth
Figure 1. Organoid cul-
ture of human colonic
epithelial cells. (A) Immu-
noﬂuorescence staining of
human colonic tissues. A
ﬂuorescence image of tis-
sue immunostained for
KRT20þ (red) and Olfm4þ
(green) is shown. DNA was
stained with Hoechst
33342 (blue). (B) Human
colonic organoids
embedded in Matrigel us-
ing a crypt as the starting
material. The brightﬁeld
images on days 0, 2, and 4
of culture at passage
numbers 0 and 1 are
shown. (C) EdU pulse la-
beling and immunoﬂuores-
cence staining (Olfm4 and
KRT20) of organoids after
4 days in culture. DNA was
stained with Hoechst
33342. Scale bars: 100 mm.
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sition into a single-layered, hollow organoid, with loss of the
crypt anatomic features (Figure 1B).39 When maintained
under a growth-factor–rich medium (EM), the organoids
predominantly comprise proliferative cells (EdUþ, Olfm4þ),
with a paucity of differentiated cells (KRT20þ) (Figure 1C).
The loss of tissue polarity likely is owing to the absence of a
polarity-deﬁning growth factor gradient within thesurrounding hydrogel as well as the inability of the Matrigel
to guide the growing organoids into the proper sized and
shaped crypt structures.22,25 Although the Matrigel-based
organoid system has been an enabling technology for
experimentation into intestinal stem cell behavior and the
creation of many intestinal disease models, the system does
not fully recapitulate the architecture and physiology of
in vivo crypts. The organoid morphology and surrounding
2018 Human Colonic Crypt Array 121hydrogel remain incompatible with many desired in-
vestigations, especially those focusing on crypt dynamics or
studying exposure to organisms and chemicals selectively
impacting one face (luminal or basal) of the intestinal
epithelium.Monolayer System Allows Self-Renewal and
Differentiation of Human Colonic Epithelial Cells
in Response to External Biochemical Cues
Wang et al25 recently developed a collagen hydrogel
scaffold that supported a self-renewing monolayer of human
colonic epithelial cells with both stem/proliferative cells as
well as the various differentiated cells (goblet cells, enter-
oendocrine cells, and colonocytes). Under the reported
growth-factor–rich culture conditions, both monolayers on
collagen and organoids within Matrigel predominantly
comprised proliferative cells, with a minority of differenti-
ated cells.25 Prior reports have shown that the stem/pro-
liferative cells of organoids can be chemically differentiatedFigure 2. Forced differentiation of human colonic epithelial ce
differentiation of the cells. Cells were cultured in expansion me
differentiation medium (DM) for 4 days. Additional molecules ad
DAPT (DM-D). (B) Fluorescence microscopy of monolayers grow
EdU, green; ALP, red; Muc2, yellow; DNA, blue. (C) Apical sur
SEM. Left: low-power magniﬁcation; right panels, high power
monolayers (6 days in expansion medium) using antibodies dire
E-cadherin (green). Nuclei were stained with Hoechst 33342 (blu
ﬂuorescence from the EdU, Muc2, and ALP stains under the vari
various culture conditions. (G) Mucin secretion by the monola
cence; Mag, magniﬁcation. *P < .05 and **P < .005.into either absorptive cells or goblet cell lineages by
modulating Wnt and Notch signals.34 To determine whether
the monolayer cells also might be force differentiated, the
monolayers were cultured in EM for 4 days and then to
media promoting differentiation for 4 days: SM (with
growth factors but without inhibitors/hormones), DM
(without growth factors, inhibitors/hormones), DM plus 5
mmol/L butyrate (DM-B), or DM plus 10 mmol/L DAPT
(DM-D) (Figure 2A and B). Cells remained proliferative in
SM owing to the presence of growth factors, but grew at a
slower rate relative to cells in EM (Figure 2B and E). Cell
proliferation largely was eliminated in DM as evidenced by a
decrease in S-phase cells as a result of the absence of growth
factors. However expression of differentiation markers
(ALPþ for colonocytes, Muc2þ for goblet cells) increased
relative to that of cells in SM (Figure 2B and E). Addition of
butyrate to DM increased ALP activity but not Muc2
expression, suggesting that the monolayers predominantly
comprised absorptive colonocytes (Figure 2B and E). Buty-
rate is produced in vivo by bacterial fermentation of ﬁberlls grown as a monolayer. (A) Schematic showing the forced
dium (EM) for 4 days and then either stem medium (SM) or
ded to the DM were 5 mmol/L butyrate (DM-B) or 10 mmol/L
n under the different differentiation media. Colors as follows:
face topography of human colonic monolayers inspected by
magniﬁcation. (D) Immunoﬂuorescence staining of epithelial
cted against b-catenin (green), ZO-1 (red), occludin (red), and
e). (E) The percentage of the monolayer surface area showing
ous culture conditions. (F) ALP activity of cell lysates under the
yer under the various culture conditions. IF, immunoﬂuores-
122 Wang et al Cellular and Molecular Gastroenterology and Hepatology Vol. 5, No. 2and is thought to act as a Notch activator.43,44 In contrast,
DAPT, a Notch inhibitor, increased Muc2 expression, sug-
gesting that Notch inhibition increased Goblet cellproduction under these conditions.43,44 These results were
consistent with the apical morphology of the monolayers
when inspected by SEM (Figure 2C): proliferative cells
2018 Human Colonic Crypt Array 123(under SM) showed a low density of stunted microvilli and
no visible secretory granules, colonocytes (under DM-B)
showed a high density of long microvilli but again without
visible secretory granules, and goblet cells (under DM-D)
showed secretory granules lining their apical surfaces but
without microvilli. In addition, tight junction proteins
(b-catenin, ZO-1, occludin, and E-cadherin) were expressed
in the monolayers (Figure 2D), suggesting that this can be
optimized to interrogate barrier function.
The presence of ALP activity and Muc2 was spatially
heterogeneous in the monolayers, which led to a large
variability in their detection when measured by ﬂuores-
cence microscopy (Figure 2B and E). For this reason, ELISA
and enzymatic assays able to measure the ALP activity and
Muc2 presence from the entire monolayer also were per-
formed. ALP enzymatic activity in the presence of DM-B was
signiﬁcantly greater than that for monolayers incubated
with SM, DM, or DM-D, again suggesting that the DM-B
monolayer was primarily colonocytes and that Notch acti-
vation drove colonocyte formation under these conditions
(Figure 2F). Muc2 secretion was increased signiﬁcantly by
incubation in DM-D relative to that of DM, and both of these
media yielded substantially more Muc2 than incubation in
either SM and DM-B (Figure 2G). Notch inhibition under
these conditions enhanced the formation of Goblet cells and
mucin presence in the monolayer cultures (Figures 2B and
4M). These data taken together suggest that cells in the
monolayer behave in a similar fashion to those in the
organoids in response to external biochemical cues.34 Thus,
the collagen hydrogel scaffold is a suitable matrix for culture
of proliferative monolayers or differentiated human colonic
epithelial cells. The ability to redirect monolayer cell fate
into either of the 2 differentiated lineages provides addi-
tional evidence for the presence of malleable stem cells
within the monolayers.Microfabrication of a Collagen Scaffold to
Support Chemical Gradients
To shape the monolayers into the architecture of in vivo
human colon crypts, we micromolded collagen hydrogels on
a porous membrane using a PDMS stamp (Figure 3A–E). A
hydrophilic, 0.4-mm PTFE membrane was selected because
of its optical transparency, low ﬂuorescence, and high
permeability. The stamps possessed an array of high-aspectFigure 3. (See previous page). Scaffolding and gradient cass
for the PDMS stamps used to micromold collagen scaffolds
(B) Transmitted light microscopy of a human colonic crypt from
used to micromold collagen. Units are shown in micrometers
micromolding process used to generate a shaped, cross-linked
the 12 scaffolds within a 12-well plate. To show the trans-scaff
brieﬂy exposed to 0.1% toluidine blue from the basal side. The t
diameter area in contact with the basal compartment. (G) Image
microwells created in the scaffold. (I) Close-up view of a regio
through a ﬂuorescein-labeled collagen scaffold. (K) Concentra
measured at the luminal (solid squares) and basal (empty c
Diffusion from basal to luminal. At 0 hours, 0.5 mL PBS was add
(100 mg/mL) was added to the basal compartment. Bottom plo
dextran (100 mg/mL) was added to the luminal compartment anratio posts with a slanted sidewall and rounded end
(Figure 3A, C, and D). During the molding process, the PDMS
stamp with posts was pressed into the collagen to create
microwells with a size and shape similar to that of the hu-
man colon crypts (Figure 3E and H–J). To strengthen the
collagen scaffold and prevent cells from deforming the
microwells, the collagen was mixed with EDC/NHS to
initiate collagen cross-linking during the molding process.45
The micromolded collagen scaffold possessed 245 micro-
wells in the central 7 mm2 area of a modiﬁed 12-well
Transwell insert (Figure 3F–J). The Transwell platform
was used because of the ease in which a gradient could be
initiated across the long axis of the microwells (z-axis of the
scaffold) (ie, simply placing different media in the basal and
luminal reservoirs). The platform also can be adapted to
other chamber types (such as Seahorse Metabolic Analyzer,
Agilent, Santa Clara, CA) by modifying the insert design.
To determine the period of time over which the basal
and luminal reservoirs could act as an inﬁnite source and
sink to support a stable gradient of growth factors across
the collagen scaffold, the diffusion of a model compound,
ﬂuorescein-dextran, across the scaffold/membrane was
measured (Figure 3K). Fluorescein-dextran (40 kilodaltons)
was chosen because it is of similar molecular weight to Wnt-
3A (39.7 kilodaltons), R-spondin (40.0 kilodaltons), and
noggin (46 kilodaltons). At 0 hour, the ﬂuorescein-dextran
concentration was (source) ¼ 100 mg/mL and (sink) ¼
0 mg/mL. At 24 hours, when the basal reservoir was the
source, the concentration was (source) ¼ 96.6 ± 3.0 mg/mL
and (sink) ¼ 2.9 ± 0.7 mg/mL (luminal reservoir). When the
direction of diffusion was reversed (ie, the basal reservoir
was now the sink), the (sink) ¼ 0.9 ± 0.2 mg/mL and the
(source) ¼ 90.2 ± 0.9 mg/mL (luminal reservoir). These data
suggested that a stable, steep chemical gradient was
established across the collagen scaffold when the ﬂuids in
the basal and luminal reservoirs were replenished every 24
hours.Construction of Polarized Colonic Crypts
Colonic crypts were constructed by growing cells on the
collagen scaffold until the cells covered the surface
including that of the sides and bottoms of the microwells
(Figure 4A). When cultured in the presence of EM, which
promotes rapid cell proliferation, the cells typically coveredette for the culture of in vitro crypts. (A) Fabrication process
mimicking the topography of epithelium of human colon.
a biopsy sample. (C) Geometry of the PDMS stamp that was
. (D) SEM image of the PDMS stamp. (E) Schematic of the
collagen scaffold on a modiﬁed Transwell insert. (F) Image of
old transport occurred only at the central area, the insert was
oluidine blue only stained the scaffold within the central 3-mm
of a single scaffold within an insert. (H) Top view of an array of
n of the scaffold in panel H. (J) Side view of a cross-section
tion of ﬂuorescein dextran (molecular weight, 40 kilodaltons)
ircles) compartments at 24, 48, and 72 hours. Top plot:
ed to the luminal compartment and 1.5 mL ﬂuorescein dextran
t: Diffusion from luminal to basal. At 0 h, 0.5 mL ﬂuorescein
d 0.5 mL PBS was added to the basal compartment.
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2018 Human Colonic Crypt Array 125the scaffolds within 7 days (Figure 4B). In contrast to native
collagen scaffolds, the cross-linked collagen scaffolds
possessed sufﬁcient strength to resist cell-induced defor-
mation of the microwell structures. The crypts within the
monolayer could be mechanically dislodged from the scaf-
folding and placed on a glass slide for microscopy as single
crypts or groups of connected crypts (Figure 4C–F). Each
in vitro crypt possessed a shape and dimensions nearly
identical to that of the in vivo structures and showed an
open luminal end mimicking in vivo crypts.
Polarization of the in vitro crypts was accomplished by
adding SM to the basal scaffold side and DM to the luminal
scaffold side. SM and DM are identical except that DM does
not contain growth factors Wnt-3A, R-spondin, and noggin.
Thus, a gradient of growth factors was established along the
basal–luminal axis of the crypt structures with the growth
factors high at the basal crypt region and low at the luminal
epithelial surface (Figure 4A). After 4 days of culture under
the SM/DM gradient, a polarized in vitro crypt array was
created (Figure 4E–G). Proliferative cells were localized to
the base of the microwell or crypt (ie, to the region with
high growth factor concentrations), while differentiated,
absorptive colonocytes were located on the luminal surface
(Figure 4E–G). Application of a growth factor gradient was
sufﬁcient to re-create an asymmetric crypt showing a pro-
liferative and nonproliferative compartment (Figure 4G and
H). Upward cell migration at a rate similar to that occurring
in vivo was shown by EdU pulse labeling and tracking the
labeled cells over 96 hours as they migrated up the crypt
axis (30 mm/day) (Figure 4I and J).46 Similar to in vivo
crypts (Figure 1A), cells of in vitro crypts expressing a dif-
ferentiation marker (KRT20þ) were located at the luminal
surface, while cells expressing a marker of colonic stem cells
(Olfm4þ) were restricted to the basal crypt region, showing
a stem cell niche (Figure 4K).38 Goblet cells and mucus also
were observed when the cells were cultured for 4 days in
EM and 6 days under gradient (Figure 4M–O). When cellsFigure 4. (See previous page). Generation of in vitro human c
in vivo crypts to in vitro crypts. Crypts were isolated from a bio
scaffold (for 5–25 days, depending on the size of the biopsy spe
The cell fragments were cultured on the shaped scaffold for 7 da
scaffold then were cultured under a biochemical gradient for a
proliferative cells are shown in red and green, respectively. (B
across the surface of the microwell array. Microwells appeared
lined with cells. (C) Side view of an in vitro–formed crypt. (D) Side
a 3-mm array under a growth factor gradient. EdU incorporatio
view) of 5 interconnected in vitro crypts after an EdU pulse (gr
cross-section from a confocal image of a polarized crypt showin
Normalized EdU incorporation along the crypt axis. Zero marks
top). (I) Directional migration of EdUþ cells over time. Images wer
EdU is green and DNA is blue. (J) Box plots of the relative prolife
divided by the crypt length (430 mm) at 0 and 96 hours after EdU
test. (K) Cross-section of in vitro crypt immunostained for KRT20
(blue). (L) Overlaid brightﬁeld and ﬂuorescence images of cros
crypts. (M–O) Mucus layer on the tissue. (M) A mucus layer was
Carnoy’s solution (after 4 days of culture in EM, and 4 days in D
crypts (4 days in EM, 6 days under a polarization gradient). Top
image. Muc2þ mucus protruded from the inside of the crypts u
imaged by ﬂuorescence microscopy. (N and O) Red depicts M
cence. Scale bars: 1 mm (E), 100 mm (B–D, F, G, I, and K), andlining the luminal tissue surface (not within the crypt) were
immunostained, the cells themselves were asymmetric,
displaying properties of an absorptive colonocyte, for
example, expressing the microvilli marker ezrin on the cell
side adjacent to the media and integrin-b4 on the cell side
contacting the collagen scaffold (Figure 4K and L). The cells
also adopted the columnar shape (height, 35 mm; width, 9
mm) typical of differentiated absorptive colonocytes in vivo.
When these human in vitro crypts were maintained under a
growth factor gradient for 32 days, the epithelium remained
as a monolayer, with polarized crypts creating a long-term
human epithelial replica.Response of In Vitro Crypts to
Gradients of SCFAs
SCFAs are produced in large quantities by bacterial
fermentation of ﬁber in the colon with the SCFAs such as
acetate, propionate, and butyrate present at millimolar
concentrations in the lumen.47 Colonic epithelial cells use
these SCFAs as their primary energy source, decreasing the
SCFA concentrations near the stem cell compartment to low
micromolar concentrations and creating steep SCFA gradi-
ents along the length of the crypt.48,49 The gradient of
butyrate (but not acetate or propionate) is thought to play a
regulatory role modulating stem cell proliferation by acting
as a histone deacetylase inhibitor at low concentration.48 To
assess whether the in vitro tissue was responsive to SCFAs,
a gradient of acetate, propionate, or butyrate in addition to
that of the growth factors was generated across the in vitro
crypts by placing the SCFA into the luminal compartment
above the tissue (Figure 5A).47,49,50 The crypts were
cultured under the SCFA gradient for 4 days (Figure 5B
and C). All 3 SCFAs increased alkaline phosphatase activity
indicative of absorptive colonocytes at the luminal surface,
but butyrate was most potent by several fold (Figure 5C
and F). Acetate and propionate gradients did not impact cellolon crypts. (A) Schematic showing the process of converting
psy, and the cells were expanded as monolayers on a planar
cimen and the number of cells banked for other experiments).
ys to create the crypt-like geometry. The cells on the shaped
t least 4 days to polarize the crypts. Differentiated and stem/
) Time-lapse brightﬁeld images showing the growth of cells
darker in these brightﬁeld images because their walls were
view of an array of crypts. (E) Low-power image (top view) of
n (green), ALP (red), DNA (blue). (F) Fluorescence image (side
een), ALP stain (red), and Hoechst-DNA labeling (blue). (G) A
g the hollow lumen. EdU incorporation (green), DNA (blue). (H)
the crypt base while 1 denotes 430 mm from the base (crypt
e at 0 and 96 hours after EdU pulse (24-h EdU pulse duration).
ration length, which was deﬁned as the length of EdUþ tissue
pulse. Ten crypt units were quantiﬁed. P < .0001 based on t
(red) and Olfm4 (green) and DNA labeled with Hoechst 33342
s-sections through the luminal surface between the in vitro
observed above a planar monolayer after ﬁxing the tissue with
M þ 10 mm DAPT). (N) Mucus was detected within the in vitro
: Brightﬁeld microscopy image. Bottom: Immunoﬂuorescence
p into the media. (O) Crypts released from the scaffold were
uc2 immunoﬂuorescence and blue is Hoechst 33342 ﬂuores-
10 mm (L).
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Figure 6. The effect of the cytokines, IFN-g and TNF-a, on in vitro human crypts. (A) Biochemical gradients applied to the
tissue. (B) Side view of representative crypts from the arrays under gradients of vehicle (0.1% BSA, control), or cytokines of 10
ng/mL IFN-g and 100 ng/mL TNF-a. Scale bar: 100 mm. Red, ALP; green, EdU-based stain; blue, DNA. (C) Confocal 3-
dimensional reconstruction of human crypt array viewed from basal side. Upper panel scale bar: 1 mm; lower panel scale
bar: 100 mm. (D) Effect of cytokine gradient on number of EdUþ cells per crypt (N ¼ 20 crypts). (E) Box plot showing the relative
position of EdUþ cells along the basal–luminal axis of crypts. Zero represents the basal end of the crypt and 1 marks the
luminal end of the crypt. (F) Normalized ALP stain for the array with the focal plane at the luminal side with a depth of ﬁeld of 60
mm (N ¼ 4 arrays). (G) A cross-sectional image through an in vitro crypt obtained by confocal ﬂuorescence imaging. Left: Crypt
in the absence of a cytokine gradient. Right: Crypt in the presence of an IFN-g/TNF-a gradient. The cells were stained with
Hoechst 33342 (blue) and propidium iodide (PI) (red). Scale bar: 100 mm. (H) Box plot depicting the number of dead cells per
cross-section of crypt (N  24). Unpaired 2-tailed Student t test: *P < .05; **P < .005. N, noggin; R, R-spondin; W, Wnt-3A.
2018 Human Colonic Crypt Array 127proliferation along the crypt axis consistent with their re-
ported behavior in organoid systems (Figure 5B–E).48 In
contrast, the butyrate gradient eliminated cell proliferation
in the luminal crypt region as shown by the absence of EdUþ
cells from the upper crypt half (Figure 5B–E). Cell prolif-
eration also was diminished but not eliminated near
the crypt base so that butyrate acted to restrict the prolif-
erating cells to the very base of the crypt. Dose-response
experiments showed that each butyrate concentration
(0.5–5 mmol/L) diminished stem/progenitor cell turnover
(Figure 5G and H), whereas only the higher concentrations
(2–5 mmol/L) enhanced absorptive colonocyte formation.
Previous SCFA studies have been reliant on colon cancer cell
lines that do not accurately model the colonic epithelium.51
Using our in vitro crypt platform, we show that butyrate
suppresses stem cell activity, which supports the hypothe-
sized effect of butyrate in human beings,48 and is capable of
inducing the differentiation of colonocytes into the absorp-
tive lineage. This latter ﬁnding has broad-rangingFigure 5. (See previous page). Modulation of in vitro human
tissue. (B) Side view of representative crypts from the arrays (s
gradient (control), acetate (0–15 mmol/L), propionate (0–5 mmo
stain; blue, DNA. (C) Top view of human crypt array. Upper panel
EdUþ cells per crypt under different gradients. (E) Relative prol
total length of the crypt for the different gradients. (F) Normalize
incorporation and ALP activity under different butyrate grad
concentration listed on the x-axis. N, noggin; R, R-spondin; W,implications because it is evidence linking microbial
metabolites with cell-fate decisions in human beings.Perturbation of In Vitro Crypts by Cytokines
Inﬂammatory cytokines such as IFN-g and TNF-a are
produced in signiﬁcant quantities by the inﬂamed intes-
tine.52 For example, IFN-g and TNF-a were found to be the
most highly induced cytokines in dextran sulfate–treated
colon.52 However, the exact effect of these cytokines has
been quite challenging to identify because of the plethora of
changes ongoing in animals with inﬂamed intestine. As a
result, many studies have relied on tissue-cultured cell lines,
such as the T84 colon carcinoma line, as surrogate reporter
systems. In this cell system, TNF-a and IFN-g synergistically
suppress proliferation.52 Further complicating the under-
standing of cytokine impact is that these molecules likely
exist at different concentrations within the crypt, which may
modulate their impact on the various cell types.52–54 Tocrypts by SCFAs. (A) Biochemical gradients applied to the
cale bar: 100 mm) under different SCFA gradients: no SCFA
l/L), and butyrate (0–5 mmol/L). Red, ALP; green, EdU-based
scale bar: 1 mm; lower panel scale bar: 100 mm. (D) Number of
iferation length, deﬁned as the length of EdUþ crypt over the
d ALP activity for the various SCFA gradients. (G and H) EdU
ients. Basal butyrate (0 mmol/L) with the luminal butyrate
Wnt-3A. *P < .05 and **P < .005.
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to inﬂammatory cytokines, the tissue was cultured under a
gradient of growth factors and cytokines (100 ng/mL TNF-a
and 10 ng/mL IFN-g) applied from the basal side for 4 days
(Figure 5A). The cytokines were included in the basal
compartment because they are produced by various cells of
the mucosal immune system in response to environmental
triggers.53 Cell proliferation as measured by EdU incorpo-
ration under a gradient of cytokines was dramatically sup-
pressed in the crypts when compared with the vehicle
control (0.1% BSA) (Figure 5B–E). The cytokines eliminated
tissue polarity because most crypts exposed to the cytokines
possessed no EdUþ cells at any location within the crypt. In
the small number of crypts that did possess EdUþ cells, the
cells were located randomly (Figure 5B and E). The number
of S-phase (EdUþ) cells per crypt decreased from 30 ± 13
for the control tissue to 1 ± 1 in that exposed to cytokine
(Figure 5D). In contrast, the cytokines only slightly
decreased the ALP activity relative to that of control
(Figure 5F). To determine whether the decrease in prolif-
eration under the cytokine gradient was a result of cell
death, the crypt arrays were stained with Hoechst 33342
and propidium iodide. The cytokine-exposed tissue
possessed signiﬁcantly more dead cells (propidium iodide
positive) than that without cytokine (Figure 6A–H); how-
ever, the absolute numbers of dead cells per crypt was low
in both instances. Thus, the loss in cell proliferation was not
owing to the death of the cells within tissue but rather
owing to diminished numbers of viable cells in the S phase.
These data show that the basally released inﬂammatory
cytokines diminish the self-renewal power of the crypts.Conclusions
Stem cells obtained from a human colon biopsy
specimen were used to create self-renewing mimics of
colonic crypts. Chemical gradients applied across the tis-
sue construct led to compartmentalization of the stem/
progenitor cells and promoted appropriate lineage differ-
entiation and cell movement replicating human crypt
biology. Application of gradients of microbiota-derived
fermentation products drove alterations in the size of
the crypts’ proliferative and differentiated compartments
as predicted to occur in vivo. Construction of primary
epithelium from human stem cells yields a physiologically
relevant mimic of the colonic epithelium, bringing to
fruition an in vitro human tissue platform for the study of
drugs and microbiome-derived compounds.References
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